Combining mercury thermoporometry with integrated gas sorption and mercury porosimetry to improve accuracy of pore-size distributions for disordered solids

The typical approach to analysing raw data, from common pore characterization methods such as gas sorption and mercury porosimetry, to obtain pore size distributions for disordered porous solids generally makes several critical assumptions that impact the accuracy of the void space descriptors thereby obtained. These assumptions can lead to errors in pore size of as much as 500%. In this work, we eliminated these assumptions by employing novel experiments involving fully integrated gas sorption, mercury porosimetry and mercury thermoporometry techniques. The entrapment of mercury following porosimetry allowed the isolation (for study) of a particular subset of pores within a much larger interconnected network. Hence, a degree of specificity of findings to particular pores, more commonly associated with use of templated, model porous solids, can also be achieved for disordered materials. Gas sorption experiments were conducted in series, both before and after mercury porosimetry, on the same sample, and the mercury entrapped following porosimetry was used as the probe fluid for theromporometry. Hence, even if one technique, on its own, is indirect, requiring unsubstantiated assumptions, the fully integrated combination of techniques described here permits the validation of assumptions used in one technique by another. Using controlled-pore glasses as model materials, mercury porosimetry scanning curves were used to establish the correct correspondence between the appropriate Gibbs–Thomson parameter, and the nature of the meniscus geometry in melting, for thermoporometry measurements on entrapped mercury. Mercury thermoporometry has been used to validate the pore sizes, for a series of sol–gel silica materials, obtained from mercury porosimetry data using the independently-calibrated Kloubek correlations. The pore sizes obtained for sol–gel silicas from porosimetry and thermoporometry have been shown to differ substantially from those obtained via gas sorption and NLDFT analysis. DRIFTS data for the samples studied has suggested that the cause of this discrepancy may arise from significant differences in the surface chemistries between the samples studied here and that used to calibrate the NLDFT potentials

A mammalianized synthetic nitroreductase gene for high-level expression

Background The nitroreductase/5-(azaridin-1-yl)-2,4-dinitrobenzamide (NTR/CB1954) enzyme/prodrug system is considered as a promising candidate for anti-cancer strategies by gene-directed enzyme prodrug therapy (GDEPT) and has recently entered clinical trials. It requires the genetic modification of tumor cells to express the E. coli enzyme nitroreductase that bioactivates the prodrug CB1954 to a powerful cytotoxin. This metabolite causes apoptotic cell death by DNA interstrand crosslinking. Enhancing the enzymatic NTR activity for CB1954 should improve the therapeutical potential of this enzyme-prodrug combination in cancer gene therapy. Methods We performed de novo synthesis of the bacterial nitroreductase gene adapting codon usage to mammalian preferences. The synthetic gene was investigated for its expression efficacy and ability to sensitize mammalian cells to CB1954 using western blotting analysis and cytotoxicity assays. Results In our study, we detected cytoplasmic protein aggregates by expressing GFP-tagged NTR in COS-7 cells, suggesting an impaired translation by divergent codon usage between prokaryotes and eukaryotes. Therefore, we generated a synthetic variant of the nitroreductase gene, called ntro, adapted for high-level expression in mammalian cells. A total of 144 silent base substitutions were made within the bacterial ntr gene to change its codon usage to mammalian preferences. The codon-optimized ntro either tagged to gfp or c-myc showed higher expression levels in mammalian cell lines. Furthermore, the ntro rendered several cell lines ten times more sensitive to the prodrug CB1954 and also resulted in an improved bystander effect. Conclusion Our results show that codon optimization overcomes expression limitations of the bacterial ntr gene in mammalian cells, thereby improving the NTR/CB1954 system at translational level for cancer gene therapy in humans